Emtage; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Emtage; Peter.The latest application filed is for "expression of novel cell tags".

Company Profile

8.6.24

Emtage; Peter - Lafayette CA
EMTAGE; Peter - GERMANTOWN MD
EMTAGE; PETER - SAN FRANCISCO CA
EMTAGE; Peter - Blacksburg VA
Emtage; Peter - San Diego CA
Emtage; Peter - Edmonton CA
Emtage, Peter - Sunnyvale CA
Emtage, Peter - Boston MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and compositions for reducing the immunogenicity of chimeric notch receptors Grant 11,325,957 - Gilbert , et al. May 10, 2	2022-05-10
Expression Of Novel Cell Tags App 20220064609 - SHAH; Rutul ; et al.	2022-03-03
Immune Cell Function App 20220047677 - Emtage; Peter ; et al.	2022-02-17
Chimeric Polypeptides And Methods Of Altering The Membrane Localization Of The Same App 20210395386 - Santoro; Stephen ; et al.	2021-12-23
Expression Of Novel Cell Tags App 20210324350 - SHAH; Rutul ; et al.	2021-10-21
Expression of novel cell tags Grant 11,118,168 - Shah , et al. September 14, 2	2021-09-14
Chimeric polypeptides and methods of altering the membrane localization of the same Grant 11,111,310 - Santoro , et al. September 7, 2	2021-09-07
CD40L-Fc FUSION POLYPEPTIDES AND METHODS OF USE THEREOF App 20210260159 - BACA; MANUEL ; et al.	2021-08-26
Expression of novel cell tags Grant 11,034,940 - Shah , et al. June 15, 2	2021-06-15
CD40L-Fc fusion polypeptides and methods of use thereof Grant 10,975,155 - Baca , et al. April 13, 2	2021-04-13
Chimeric Transmembrane Proteins And Uses Thereof App 20210015864 - Emtage; Peter ; et al.	2021-01-21
TGF-beta Receptors and Methods of Use App 20200397823 - WYMAN; Sarah ; et al.	2020-12-24
Chimeric Transmembrane Receptors And Uses Thereof App 20200384030 - Emtage; Peter ; et al.	2020-12-10
Chimeric Transmembrane Proteins And Uses Thereof App 20200002402 - Emtage; Peter ; et al.	2020-01-02
Methods Of Making Bispecific Anti-cd307e And Anti-bcma Chimeric Antigen Receptors And Uses Of The Same App 20190194340 - Emtage; Peter ; et al.	2019-06-27
Single- And Multi-chain Chimeric Antigen Receptors App 20190194617 - Emtage; Peter ; et al.	2019-06-27
Improved Therapeutic Control of Proteolytically Sensitive, Destabilized Forms of Interleukin-12 App 20190062394 - YARLAGADDA; Ramya ; et al.	2019-02-28
Methods And Compositions For Reducing The Immunogenicity Of Chimeric Notch Receptors App 20180362603 - Gilbert; Amy ; et al.	2018-12-20
Expression Of Novel Cell Tags App 20180362940 - Shah; Rutul ; et al.	2018-12-20
Chimeric Polypeptides And Methods Of Altering The Membrane Localization Of The Same App 20180319890 - Santoro; Stephen ; et al.	2018-11-08
Cd33 Specific Chimeric Antigen Receptors App 20180002397 - Shah; Rutul ; et al.	2018-01-04
CD40L-Fc Fusion Polypeptides And Methods Of Use Thereof App 20170327588 - Baca; Manuel ; et al.	2017-11-16
Bioactive Purified Hspe7 Compositions App 20110142873 - Rowse; Gerry ; et al.	2011-06-16
Adjuvant Compositions Comprising Poly-ic And A Cationic Polymer App 20110038888 - Emtage; Peter	2011-02-17
Double-stranded Locked Nucleic Acid Compositions App 20090041809 - Emtage; Peter	2009-02-12
Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells Grant 7,378,253 - Dedera , et al. May 27, 2	2008-05-27
Methods of therapy and diagnosis using targeting of cells that express Ly-9 App 20040109863 - Emtage, Peter	2004-06-10
Enhancing the immune response to an antigen by presensitzing with an inducing agent prior to immunizing with the agent and the antigen App 20040009185 - Emtage, Peter ; et al.	2004-01-15
MAGE-A1 peptides for treating or preventing cancer App 20030148973 - Emtage, Peter ; et al.	2003-08-07
Immunogenic targets for melanoma App 20030113919 - Emtage, Peter ; et al.	2003-06-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.